Applied DNA Sciences Management
Management criteria checks 4/4
Applied DNA Sciences' CEO is James Hayward, appointed in Apr 2006, has a tenure of 18.25 years. total yearly compensation is $468.00K, comprised of 96.2% salary and 3.8% bonuses, including company stock and options. directly owns 0.066% of the company’s shares, worth €2.48K. The average tenure of the management team and the board of directors is 9.4 years and 8.4 years respectively.
Key information
James Hayward
Chief executive officer
US$468.0k
Total compensation
| CEO salary percentage | 96.2% |
| CEO tenure | 18.3yrs |
| CEO ownership | 0.07% |
| Management average tenure | 9.4yrs |
| Board average tenure | 8.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$13m |
| Dec 31 2023 | n/a | n/a | -US$7m |
| Sep 30 2023 | US$468k | US$450k | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$7m |
| Mar 31 2023 | n/a | n/a | -US$5m |
| Dec 31 2022 | n/a | n/a | -US$7m |
| Sep 30 2022 | US$2m | US$450k | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$15m |
| Dec 31 2021 | n/a | n/a | -US$14m |
| Sep 30 2021 | US$1m | US$400k | -US$14m |
| Jun 30 2021 | n/a | n/a | -US$14m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | n/a | n/a | -US$15m |
| Sep 30 2020 | US$451k | US$133k | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$10m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | n/a | n/a | -US$8m |
| Sep 30 2019 | US$375k | US$233k | -US$9m |
| Jun 30 2019 | n/a | n/a | -US$11m |
| Mar 31 2019 | n/a | n/a | -US$12m |
| Dec 31 2018 | n/a | n/a | -US$12m |
| Sep 30 2018 | US$481k | US$250k | -US$12m |
| Jun 30 2018 | n/a | n/a | -US$11m |
| Mar 31 2018 | n/a | n/a | -US$11m |
| Dec 31 2017 | n/a | n/a | -US$12m |
| Sep 30 2017 | US$546k | US$282k | -US$13m |
Compensation vs Market: James's total compensation ($USD468.00K) is about average for companies of similar size in the German market ($USD499.33K).
Compensation vs Earnings: James's compensation has been consistent with company performance over the past year.
CEO
James Hayward (70 yo)
18.3yrs
Tenure
US$468,000
Compensation
Dr. James A. Hayward, Ph D., Sc D., has been Chief Executive Officer and Chairman of Applied DNA Sciences, Inc. (Formerly Known as Prohealth Medical Tech, Inc) since March 17, 2006 and since June 12, 2007...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 18.3yrs | US$468.00k | 0.066% € 2.5k | |
| Chief Financial Officer | 9.4yrs | US$501.00k | 0.020% € 759.3 | |
| COO, Chief Information Officer & Secretary | 11.1yrs | US$542.75k | 0.023% € 865.6 | |
| Chief Legal Officer & Executive Director of Business Development | 3.3yrs | US$501.00k | 0.027% € 1.0k | |
| Executive Director of Investor Relations & Corporate Communications | 4yrs | no data | no data |
9.4yrs
Average Tenure
57yo
Average Age
Experienced Management: UDJ's management team is seasoned and experienced (9.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 18.8yrs | US$468.00k | 0.066% € 2.5k | |
| Chairman of Strategic Advisory Board & Independent Director | 8.4yrs | US$152.50k | 0.00095% € 35.9 | |
| Independent Director | 18.3yrs | US$162.50k | 0.00077% € 29.1 | |
| Member of Strategic Advisory Board | 7.5yrs | no data | no data | |
| Independent Director | 9.6yrs | US$155.00k | 0.00027% € 10.2 | |
| Independent Director | 18.3yrs | US$151.25k | 0.000040% € 1.5 | |
| Member of Strategic Advisory Board | 7.8yrs | no data | no data | |
| Member of Strategic Advisory Board | 8.4yrs | no data | no data | |
| Independent Director | 7.1yrs | US$153.75k | 0.00038% € 14.4 | |
| Member of Strategic Advisory Board | 5.5yrs | no data | no data |
8.4yrs
Average Tenure
73yo
Average Age
Experienced Board: UDJ's board of directors are considered experienced (8.4 years average tenure).